State officials to review tax credit for generic drug maker Teva

mobile.nj.com — State officials to review tax credit for generic drug maker Teva Sarah Portlock / The Star-Ledger Posted: 04/10/2012 7:30 AM The Israeli generic drug maker Teva is up for a Grow New Jersey tax credit worth $15 million at today's Economic Development Authority board meeting.
Jenna Portnoy Government Reporter, The Allentown Lehigh Valley Morning Call @jennaportnoy
Teva Pharma deal on deck. Wheels apparently set in motion long before @GovChristie's trip to Israel, via @sarahportlock t.co/dtTYFN6O